Nobex Corporation Overview
- Year Founded
-
1993

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$5M
Nobex Corporation General Information
Description
Developer of an oral insulin product for diabetes. The company offers Oratonin, an oral modified salmon calcitonin with antibone-resorptive and analgesic properties for bone disorders; APAZA compound, an oral tablet for inflammatory bowel disease and insulin in an oral tablet for diabetes.
Contact Information
Corporate Office
- 617 Davis Drive
- Suite 100
- Morrisville, NC 27709
- United States
Corporate Office
- 617 Davis Drive
- Suite 100
- Morrisville, NC 27709
- United States
Nobex Corporation Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Merger/Acquisition | 28-Mar-2006 | $5M | Completed | Generating Revenue | ||
8. Bankruptcy: Admin/Reorg | 01-Dec-2005 | Completed | Generating Revenue | |||
7. Later Stage VC | 14-May-2003 | Completed | Generating Revenue | |||
6. Later Stage VC (Series F) | 14-Aug-2002 | Completed | Generating Revenue | |||
5. Later Stage VC (Series E) | 03-Jun-1999 | Completed | Product Development | |||
4. Debt - General | 05-Jun-1996 | Completed | ||||
3. Later Stage VC (Series C) | 23-Nov-1994 | Completed | Product Development | |||
2. Early Stage VC (Series A) | 03-Jun-1994 | $1.4M | Completed | Product Development | ||
1. Early Stage VC (Series B) | 01-Apr-1994 | $1.4M | $1.4M | Completed | Product Development |
Nobex Corporation Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series F | ||||||||
Series E | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 1,187,049 | $0.010000 | $1.39 | $1.39 | $1.39 | 2.55% | ||
Series A | 3,931,909 | $0.010000 | $2 | $1.39 | $2 | 8.46% |
Nobex Corporation Patents
Nobex Corporation Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-8314214-B2 | Synthesis of azo bonded immunoregulatory compounds | Inactive | 07-Jul-2004 | ||
US-20110201792-A1 | Synthesis of azo bonded immunoregulatory compounds | Active | 07-Jul-2004 | ||
US-20130096286-A1 | Synthesis of azo bonded immunoregulatory compounds | Active | 07-Jul-2004 | ||
US-8754197-B2 | Synthesis of azo bonded immunoregulatory compounds | Active | 07-Jul-2004 | ||
US-20090281023-A9 | Mixtures of calcitonin drug-oligomer conjugates and methods of use in pain treatment | Inactive | 24-Jun-2003 | A61K38/23 |
Nobex Corporation Former Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AEA Investors | PE/Buyout | Minority | ||
American Express | Corporation | Minority | ||
Crescendo Ventures | Venture Capital | Minority | ||
Endpoint Late Stage Fund | Venture Capital | Minority | ||
HealthCap | Venture Capital | Minority |
Nobex Corporation FAQs
-
When was Nobex Corporation founded?
Nobex Corporation was founded in 1993.
-
Where is Nobex Corporation headquartered?
Nobex Corporation is headquartered in Morrisville, NC.
-
What industry is Nobex Corporation in?
Nobex Corporation’s primary industry is Pharmaceuticals.
-
Is Nobex Corporation a private or public company?
Nobex Corporation is a Private company.
-
What is the current valuation of Nobex Corporation?
The current valuation of Nobex Corporation is
. -
What is Nobex Corporation’s current revenue?
The current revenue for Nobex Corporation is
. -
How much funding has Nobex Corporation raised over time?
Nobex Corporation has raised $69.6M.
-
Who are Nobex Corporation’s investors?
AEA Investors, American Express, Crescendo Ventures, Endpoint Late Stage Fund, and HealthCap are 5 of 10 investors who have invested in Nobex Corporation.
-
When was Nobex Corporation acquired?
Nobex Corporation was acquired on 28-Mar-2006.
-
Who acquired Nobex Corporation?
Nobex Corporation was acquired by Biocon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »